LOE, slew of companies launching
all such literature is pre-clinical
For supplement brands, the better question is not simply Which ingredient is better? The better question is: Which ingredient fits your product format, label claim, target consumer, dosage, taste profile, cost target, and manufacturing process
The genetic layer a prescription doesn't capture One thing no GLP-1 program screens for is the inherited biology under your response
Cystine enters cells through the cystine/glutamate reverse transporter (system Xc ) and is then reduced via the glutathione or thioredoxin reductase 1-dependent cysteine reduction pathway to generate cysteine and promote GSH synthesis
Its ability to selectively induce lipolytic processes without the side effects of IGF-1 stimulation or glucose metabolism interference makes it a unique research tool